Background
==========

Allergic contact dermatitis (ACD) is a common inflammatory skin disease characterized by eczema and recurrent episodes of itching \[[@B1]\]. The disease affects a significant proportion of the population, with prevalence rates of 7.2% to 18.6% in Europe \[[@B2],[@B3]\], and the incidence is increasing due to repeated exposure to sensitizing chemicals. ACD is a type IV delayed-type hypersensitivity response caused mainly by reactive T helper 1 (Th1) and interferon (IFN)γ producing CD8^+^T cells, at site of contact with small chemical haptens in previously exposed, and immunologically sensitized, individuals \[[@B4]\]. Dendritic cells (DC) in the epidermis initiate the immune reactions by responding to haptens bound to self-molecules subsequently activating T cell-mediated immunity.

The REACH (Registration, Evaluation, and Authorization of Chemicals) regulation requires that all new and existing chemicals within the European Union, involving approximately 30.000 chemicals, should be tested for hazardous effects \[[@B5]\]. As the identification of potential sensitizers currently requires animal testing, the REACH legislation will have a huge impact on the number of animals needed for testing. Further, the 7th Amendment to the Cosmetics Directive posed a ban on animal tests for the majority of cosmetic ingredients for human use, to be in effect by 2009, with the exceptions of some tests by 2013. Thus, development of reliable in vitro alternatives to experimental animals for the assessment of sensitizing capacity of chemicals is urgent. To date, no non-animal replacements are available for identification of skin sensitizing chemicals, instead the preferred assay is the mouse Local Lymph Node Assay (LLNA) \[[@B6]\], followed by the Guinea pig maximization test (GPMT) \[[@B7]\]. An *in vitro*alternative to these animal models should exhibit improved reliability, accuracy and importantly correlate to human reactivity.

DCs play key roles in the immune response by bridging the essential connections between innate and adaptive immunity. Upon stimulation, they can rapidly produce large amounts of mediators that affect chemotaxis and activation of other cells at the site of inflammation, and can selectively respond to various pathogens and environmental factors, by fine-tuning the cellular response through antigen-presentation. Thus, exploring and utilizing the immunological decision-making by DCs during stimulation with sensitizers, could serve as a potent test strategy for the prediction of sensitization.

Factors that complicate and impede the use of primary DCs as a test platform include adaptable phenotypes and specialized functions of different DC subpopulations, in addition to their wide and sparse distribution. Thus, the development of assays based on the predictability of DC function must rely on alternative cell types or mimics of *in vivo*DCs. For this purpose, a cell line with DC characteristics would be advantageous, as it constitutes a stable, reproducible and unlimited supply of cells. MUTZ-3 is an unlimited source of CD34^+^DC progenitors. Upon differentiation, MUTZ-3 can acquire phenotypes comparable to immature DCs or Langerhans-like DCs \[[@B8]\], present antigens through CD1d, MHC class I and II and induce specific T-cell proliferation \[[@B9]\]. Differentiated MUTZ-3 can also display a mature transcriptional and phenotypic profile upon stimulation with inflammatory cytokines \[[@B10]\].

In this report, we present a novel test principle for the prediction of skin sensitizers. To simplify the assay procedures and increase reproducibility, we employed progenitor MUTZ-3 cells, without further differentiation, and subjected the cells to stimulation with a large panel of sensitizing chemicals, non-sensitizing chemicals, and controls. The transcriptional response to chemical stimulation was assessed by genome-wide profiling. From data analysis, a biomarker signature of 200 transcripts was identified, which completely separated the response induced by sensitizing chemicals vs. non-sensitizing chemicals and the predictive power of the signature was illustrated, using ROC curves. The biomarker signature includes transcripts involved in relevant biological pathways, such as oxidative stress, DC maturation and cytokine responses, which further could shed light on molecular interactions involved in the process of sensitization. In conclusion, we have identified a biomarker signature with potent predictive power, which we propose as an in vitro assay for the identification of human sensitizing chemicals.

Results
=======

The cellular rationale of the in vitro cell culture system
----------------------------------------------------------

DCs are essential immunoregulatory cells of the immune system demonstrated by their unique property to recognize antigen for the initiating of T cell responses, and their potent regulatory function in skewing immune responses. This makes them obvious targets for assay development. However, primary DCs constitute a heterogeneous and minor population of cells not suited for screening and the choice would be a human DC-like cell line, with characteristics compared to primary DCs. Since no leukemic cell line with DC-like properties has been reported \[[@B11]\], the generation of human DC-like cell lines relies on available myeloid leukemia cell lines. MUTZ-3 is a human acute myelomonocytic leukemia cell line with a potent ability to mimic primary human DCs \[[@B11]\]. Similar to immature primary DCs, MUTZ-3 progenitors express CD1a, HLA-DR and CD54, as well as low levels of CD80 and CD86 (Figure [1](#F1){ref-type="fig"}). The MUTZ-3 population also contains three subpopulations of CD14^+^, CD34^+^and double negative cells, previously reported to be transitional differentiation steps from a proliferative CD34^+^progenitor into a non-proliferative CD14^+^DC precursor \[[@B8]\]. Consequently, constitutively differentiating progenitor MUTZ-3 cells were used as the basis for a test system.

![**Phenotype of MUTZ-3 cells prior to stimulation with sensitizing and non-sensitizing chemicals**. Cell surface expression levels of CD14, CD1a, CD34, CD54, CD80, CD86 and HLA-DR were assessed with flow cytometry. Gates were set to exclude debris and dead cells, and quadrants were established by comparing with relevant isotype controls. Results are shown from one representative experiment out of six.](1471-2164-12-399-1){#F1}

CD86 surface expression in response to sensitizer stimulation
-------------------------------------------------------------

CD86 is the most extensively studied biomarker for sensitization to date, using e.g. monocyte derived dendritic cells (MoDCs) or human cell lines and their progenitors, such as THP-1, U-937 and KG-1. Thus, as a reference, cell surface expression of CD86 was measured with flow cytometry after 24 h stimulation, using 20 sensitizers and 20 non-sensitizers, as well as vehicle controls (Figure [2](#F2){ref-type="fig"}). CD86 was significantly up-regulated on cells stimulated with 2-aminophenol, kathon CG, 2-nitro-1,4-phenylendiamine, 2,4-dinitrochlorobenzene, 2-hydroxyethyl acrylate, cinnamic aldehyde, p-phenylendiamine, resorcinol, potassium dichromate, and 2-mercaptobenzothiazole. Hence, an assay based on measurement of a single biomarker, such as CD86, would give a sensitivity of 50% and a specificity of 100%. Consequently, CD86 cannot classify skin sensitizers, using a system based on MUTZ-3 cells.

![**Changes in CD86 expression following stimulation with sensitizing and non-sensitizing chemicals**. Cell surface expression levels of CD86 were monitored after stimulation with chemicals for 24 h. A). Chemical-induced up regulation of CD86, in terms of changes in frequency of positive cells, were determined by flow cytometry, as exemplified by the comparison of 2-aminophenol-stimulated cells (right dotplot) and unstimulated controls (left dot plot). Results are shown from one representative experiment out of three. Gates were set to exclude debris and dead cells, and quadrants were established by comparing with relevant isotype controls. B) Compilation of frequencies of CD86-positive cells after 24 h of stimulation. Statistical analysis was performed using Student\'s *t*test. \**p*\< 0.05, \# *p*\< 0.01.](1471-2164-12-399-2){#F2}

Analysis of the transcriptional profiles in chemically stimulated MUTZ-3 cells
------------------------------------------------------------------------------

The genomic expression arrays were then used to test the same 20 sensitizers and 20 non-sensitizers, in triplicates. The vehicle controls, such as DMSO and distilled water, were included in twelve replicates. In total, a data set was generated based on 144 samples. RMA normalization and quality controls of the samples revealed that the oxazolone and cinnamic aldehyde samples were significant outliers and had to be removed, or they would have dominated the data set prohibiting biomarker identification (data not shown). In addition, one of the replicates of potassium permanganate had to be removed due to a faulty array. This left a data set consisting of 137 samples, each with data from measurements of 29,141 transcripts. In order to mine the data set for information specific for sensitizers vs. non-sensitizers, the software Qlucore Omics Explorer 2.1 was used, which enable real time principal component analysis (PCA) analysis. The input genes were at the same time sorted after desired criteria, i.e. sensitizers and non-sensitizers, based on ANOVA p-value selection. Two different ANOVA analyses were performed (Figure [3](#F3){ref-type="fig"}). First, Figure [3A](#F3){ref-type="fig"} and [3B](#F3){ref-type="fig"} show PCA plots based on 1010 transcripts with a p-value of ≤ 2.0 × 10^-6^, from a one-way ANOVA analysis, comparing sensitizing vs. non-sensitizing chemicals. As can be seen in Figure [3A](#F3){ref-type="fig"}, a clear discrimination can be made between the two groups, with non-sensitizers forming a condensed cloud in the lower part of the figure (green), while sensitizers stretch upwards in various directions (red). However, a complete separation is not achieved between the two groups at this level of significance. From Figure [3B](#F3){ref-type="fig"}, now colored according to stimulating agent, it is evident that one or more replicate of glyoxal, eugenol, hexylcinnamic aldehyde, isoeugenol, resorcinol, penicillin G and ethylendiamine grouped together with the control group. In addition, one replicate or more of the non-sensitizers tween 80, octanoic acid and phenol grouped closely with the sensitizers. Secondly, Figure [3C](#F3){ref-type="fig"} and [3D](#F3){ref-type="fig"} show PCA plots based on 1137 genes, with p-values ≤ 7.0 × 10^-21^, from a multi-group ANOVA analysis, comparing each individual stimulation. Identifying this large number of genes at this level of significance provided strong indications of the power in the data set. In Figure [3D](#F3){ref-type="fig"}, it is clear that the replicates group together, indicating high quality data. The triplicate samples of potassium dichromate have a discrete profile, which demonstrate a substantial impact of the cells compared to non-sensitizers. Furthermore, 2-hydroxyethyl acrylate, 2-aminophenol, kathon CG, formaldehyde, 2-nitro-1,4-phenylendiamine, 2,4-dinitrochlorobenzoic acid, p-phenylendiamine, 2-mercaptobenzothiazole, cinnamic alcohol and resorcinol have replicates that group together, separate from the negative group. Still, as can be seen in Figure [3C](#F3){ref-type="fig"} as well as in 3A, complete separation is not achieved with neither of the gene signatures of 1010 and 1137 genes both selected on p-values.

![**Principal component analysis of transcripts differentially expressed after chemical stimulation**. mRNA levels in MUTZ-3 cells stimulated for 24 h with 20 sensitizing and 20 non-sensitizing chemicals were assessed with transcriptomics, using Affymetrix Human Gene 1.0 ST arrays. Structures and similarities in the gene expression data set were investigated, using principal component analysis (PCA) in the software Qlucore. A) PCA of genes differentially expressed in cells stimulated with sensitizing (red) versus non-sensitizing (green) chemicals (1010 genes identified with one-way ANOVA). B) PCA of genes differentially expressed in cells stimulated with sensitizing versus non-sensitizing chemicals (1010 genes), but now samples are colored by the compound used for stimulation. C) PCA of genes differentially expressed when comparing the different stimulations with 2-way ANOVA (1137 genes). Samples are colored according to sensitizing (red) and non-sensitizing (green) chemicals. D) PCA of genes differentially expressed when comparing the different stimulations with 2-way ANOVA (1137 genes), but now samples are colored by the compound used for stimulation. P, p-value from ANOVA. Q, p-value corrected for multiple hypothesis testing.](1471-2164-12-399-3){#F3}

Backward elimination identifies genes with the most discriminatory power
------------------------------------------------------------------------

Even though the data set contains genes with p-values down to 1 × 10^-17^, lowering the p-value cutoff did not achieve complete separation between sensitizers and non-sensitizers. Gene signatures entirely selected on p-values does not provide the best possible predictive power, since the information is *per se*not orthogonal. To further reduce the number of transcripts for a predictive biomarker signature, we employed an algorithm for backward elimination (Figure [4A](#F4){ref-type="fig"}). The algorithm removes genes one by one while taking into account not only the impact of genes individually, but how they perform collectively with the entire selected gene signature. For each gene eliminated, the Kullback-Leibler divergence (KLD) value is lowered, until a breakpoint is reached, at which point 200 genes remained. Continuing eliminating genes at this point causes the KLD to rise again, indicating that information is being lost (Figure [4A](#F4){ref-type="fig"}). Therefore, the 200 genes with lowest KLD value were selected for further analysis. PCA of the 200 analytes now revealed that they have the ability to completely separate sensitizers from non-sensitizers, indicating that these transcripts can be used as predictors for sensitizing properties of unknown samples (Figure [4B](#F4){ref-type="fig"}). Importantly, by coloring the samples in the PCA by their potency, according to LLNA, it is clear that potency can also be predicted (Figure [4C](#F4){ref-type="fig"}), as extreme and strong sensitizers tend to group further from the non-sensitizers, while moderate and extreme sensitizers group closer to non-sensitizers. The 200 genes are termed the \"Prediction Signature\" and their identities are listed in Table [1](#T1){ref-type="table"}. In addition, the transcriptional profiles of the differentially expressed genes are presented in a heatmap (Figure [5](#F5){ref-type="fig"}).

![**Identification and PCA analysis of Prediction Signature**. A) The number of differentially expressed significant genes in cells stimulated with sensitizing versus non-sensitizing chemicals (1010 genes) was reduced, using Backward Elimination. The lowest KLD is observed after elimination of 810 analytes, referred to as the Breakpoint. The remaining 200 genes are considered to be the top predictors in the data set, and are termed Prediction Signature. B) Complete separation between sensitizers (red) and non-sensitizers (green) is observed with PCA of the Prediction Signature. C) Same PCA as in B, now with samples colored according to their potency in LLNA.](1471-2164-12-399-4){#F4}

###### 

Prediction Signature

  Gene Title                                                                                                                                                                     Gene Symbol                      Entrez Gene ID                 Affymetrix HuGene 1.0 ST ID   Validation Call frequency (%)
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ -------------------------------- ------------------------------ ----------------------------- -------------------------------
  4-aminobutyrate aminotransferase                                                                                                                                               ABAT                             18                             7993126                       30
  abhydrolase domain containing 5                                                                                                                                                ABHD5                            51099                          8079153                       85
  alkaline ceramidase 2                                                                                                                                                          ACER2                            340485                         8154563                       95
  ATP citrate lyase                                                                                                                                                              ACLY                             47                             8015460                       85
  actin-related protein 10 homolog (S. cerevisiae)                                                                                                                               ACTR10                           55860                          7974587                       75
  ADAM metallopeptidase domain 20                                                                                                                                                ADAM20                           8748                           7979927                       35
  aldehyde dehydrogenase 18 fam., member A1                                                                                                                                      ALDH18A1                         5832                           7935230                       75
  aldehyde dehydrogenase 1 fam., member B1                                                                                                                                       ALDH1B1                          219                            8155327                       70
  anaphase promoting complex subunit 1                                                                                                                                           ANAPC1                           64682                          8043349                       55
  anaphase promoting complex subunit 5                                                                                                                                           ANAPC5                           51433                          7967149                       25
  ankyrin repeat, fam. A (RFXANK-like), 2                                                                                                                                        ANKRA2                           57763                          8112596                       100
  ADP-ribosylation factor GTPase activating protein 3                                                                                                                            ARFGAP3                          26286                          8076515                       55
  Rho GTPase activating protein 9                                                                                                                                                ARHGAP9                          64333                          7964436                       75
  ankyrin repeat and SOCS box-containing 7                                                                                                                                       ASB7                             140460                         7986433                       65
  ATPase, H+ transporting, lysosomal 38 kDa, V0 subunit d1//ATPase, H+ transporting, lysosomal 38 kDa, V0 subunit d1                                                             ATP6V0D1//ATP6V0D1               9114//9114                     8002041                       10
  ATPase, H+ transporting, lysosomal 9 kDa, V0 subunit e1                                                                                                                        ATP6V0E1                         8992                           8110022                       75
  ATPase, H+ transporting, lysosomal 50/57 kDa, V1 subunit H                                                                                                                     ATP6V1H                          51606                          8150797                       100
  B-cell CLL/lymphoma 7A                                                                                                                                                         BCL7A                            605                            7959354                       85
  bridging integrator 2                                                                                                                                                          BIN2                             51411                          7963289                       80
  bleomycin hydrolase                                                                                                                                                            BLMH                             642                            8014008                       15
  brix domain containing 1//ribosome production factor 2 homolog (S. cerevisiae)                                                                                                 BXDC1//RPF2                      84154//84154                   8062211                       40
  chromosome 11 open reading frame 61                                                                                                                                            C11orf61                         79684                          7952445                       55
  chromosome 11 open reading frame 67//integrator complex subunit 4                                                                                                              C11orf67//INTS4                  28971//92105                   7942783                       50
  chromosome 12 open reading frame 57                                                                                                                                            C12orf57                         113246                         7953564                       40
  chromosome 13 open reading frame 18                                                                                                                                            C13orf18                         80183                          7971486                       50
  chromosome 15 open reading frame 24                                                                                                                                            C15orf24                         56851                          7987172                       50
  chromosome 19 open reading frame 46//alkB, alkylation repair homolog 6 (E. coli)                                                                                               C19orf46//ALKBH6                 163183//84964                  8036242                       30
  chromosome 19 open reading frame 54                                                                                                                                            C19orf54                         284325                         8036956                       95
  chromosome 1 open reading frame 174                                                                                                                                            C1orf174                         339448                         7911897                       40
  chromosome 1 open reading frame 183                                                                                                                                            C1orf183                         55924                          7918552                       85
  chromosome 20 open reading frame 111                                                                                                                                           C20orf111                        51526                          8066402                       65
  chromosome 20 open reading frame 24                                                                                                                                            C20orf24                         55969                          8062326                       20
  chromosome 3 open reading frame 62//ubiquitin specific peptidase 4 (proto-oncogene)                                                                                            C3orf62//USP4                    375341//7375                   8087374                       40
  chromosome 9 open reading frame 89                                                                                                                                             C9orf89                          84270                          8156404                       100
  coactivator-associated arginine methyltransferase 1                                                                                                                            CARM1                            10498                          8025766                       60
  CD33 molecule                                                                                                                                                                  CD33                             945                            8030804                       45
  CD86 molecule                                                                                                                                                                  CD86                             942                            8082035                       45
  CD93 molecule                                                                                                                                                                  CD93                             22918                          8065359                       50
  cytochrome c oxidase subunit VIIa polypeptide 2 like                                                                                                                           COX7A2L                          9167                           8051777                       45
  corticotropin releasing hormone binding protein                                                                                                                                CRHBP                            1393                           8106418                       45
  chondroitin sulfate N-acetylgalactosaminyltransferase 2                                                                                                                        CSGALNACT2                       55454                          7927146                       90
  cytochrome P450, fam. 51, subfam. A, polypeptide 1                                                                                                                             CYP51A1                          1595                           8140864                       85
  DDRGK domain containing 1                                                                                                                                                      DDRGK1                           65992                          8064601                       60
  DEAD (Asp-Glu-Ala-As) box polypeptide 19A                                                                                                                                      DDX19A                           55308                          7997059                       95
  DEAD (Asp-Glu-Ala-Asp) box polypeptide 21                                                                                                                                      DDX21                            9188                           7927936                       60
  24-dehydrocholesterol reductase                                                                                                                                                DHCR24                           1718                           7916432                       100
  7-dehydrocholesterol reductase                                                                                                                                                 DHCR7                            1717                           7950067                       80
  DEAH (Asp-Glu-Ala-His) box polypeptide 33                                                                                                                                      DHX33                            56919                          8011861                       100
  DnaJ (Hsp40) homolog, subfam. B, member 4                                                                                                                                      DNAJB4                           11080                          7902512                       100
  DnaJ (Hsp40) homolog, subfam. B, member 9                                                                                                                                      DNAJB9                           4189                           8135480                       25
  DnaJ (Hsp40) homolog, subfam. C, member 5                                                                                                                                      DNAJC5                           80331                          8064208                       10
  DnaJ (Hsp40) homolog, subfam. C, member 9                                                                                                                                      DNAJC9                           23234                          7934320                       55
  DNA-damage regulated autophagy modulator 2//choline/ethanolamine phosphotransferase 1                                                                                          DRAM2//CEPT1                     128338//10390                  7918474                       100
  D-tyrosyl-tRNA deacylase 1 homolog (S. cerevisiae)                                                                                                                             DTD1                             92675                          8061211                       45
  ER degradation enhancer, mannosidase alpha-like 2                                                                                                                              EDEM2                            55741                          8065855                       80
  ecotropic viral integration site 2B                                                                                                                                            EVI2B                            2124                           8014063                       60
  fam. with sequence similarity 36, member A//non-protein coding RNA 201                                                                                                         FAM36A//NCRNA00201               116228//284702                 7911085                       15
  fam. with sequence similarity 86, member A                                                                                                                                     FAM86A                           196483                         7999304                       25
  Fas (TNF receptor superfam., member 6)                                                                                                                                         FAS                              355                            7929032                       70
  fatty acid synthase                                                                                                                                                            FASN                             2194                           8019392                       100
  F-box protein 10//translocase of outer mitochondrial membrane 5 homolog (yeast)                                                                                                FBXO10//TOMM5                    26267//401505                  8161229                       40
  MGC44478                                                                                                                                                                       FDPSL2A                          619190                         8140443                       55
  ferredoxin reductase                                                                                                                                                           FDXR                             2232                           8018236                       40
  forkhead box O4                                                                                                                                                                FOXO4                            4303                           8168205                       80
  ferritin, heavy polypeptide-like 5                                                                                                                                             FTHL5                            2509                           8126948                       95
  fucosidase, alpha-L- 2, plasma                                                                                                                                                 FUCA2                            2519                           8129974                       20
  growth arrest-specific 2 like 3                                                                                                                                                GAS2L3                           283431                         7957850                       70
  ganglioside induced differentiation associated protein 2                                                                                                                       GDAP2                            54834                          7918955                       80
  growth differentiation factor 11                                                                                                                                               GDF11                            10220                          7956026                       65
  glutaredoxin (thioltransferase)                                                                                                                                                GLRX                             2745                           8113214                       90
  guanine nucleotide binding protein-like 3 (nucleolar)-like                                                                                                                     GNL3L                            54552                          8167797                       85
  glucosamine-phosphate N-acetyltransferase 1                                                                                                                                    GNPNAT1                          64841                          7979196                       90
  glutathione reductase                                                                                                                                                          GSR                              2936                           8150112                       40
  GTF2I repeat domain containing 2//GTF2I repeat domain containing 2B                                                                                                            GTF2IRD2//GTF2IRD2B              84163//389524                  8133549 and 8140170           50 and 30
  general transcription factor IIIC, polypeptide 2, beta 110 kDa                                                                                                                 GTF3C2                           2976                           8051075                       55
  HMG-box transcription factor 1//component of oligomeric golgi complex 5                                                                                                        HBP1//COG5                       26959//10466                   8135392                       65
  histone cluster 1, H1c                                                                                                                                                         HIST1H1C                         3006                           8124397                       45
  histone cluster 1, H1e                                                                                                                                                         HIST1H1E                         3008                           8117377                       95
  histone cluster 1, H2ae                                                                                                                                                        HIST1H2AE                        3012                           8117408                       45
  histone cluster 1, H2be                                                                                                                                                        HIST1H2BE                        8344                           8117389                       15
  histone cluster 1, H3g                                                                                                                                                         HIST1H3G                         8355                           8124440                       35
  histone cluster 1, H3j                                                                                                                                                         HIST1H3J                         8356                           8124537                       60
  histone cluster 1, H4a                                                                                                                                                         HIST1H4A                         8359                           8117334                       10
  histone cluster 2, H2ac//histone cluster 2, H2aa3//histone cluster 2, H2aa4                                                                                                    HIST-2H2AC//2H2AA3//2H2AA4       8338//8337//723790             7905079 and 7919619           75 and 75
  histone cluster 2, H2bf//histone cluster 2, H2be//histone cluster 2, H2ba                                                                                                      HIST-2H2BF//2H2BE//2H2BA         440689//8349//337875           7919606                       50
  high-mobility group box 3                                                                                                                                                      HMGB3                            3149                           8170468                       5
  3-hydroxy-3-methylglutaryl-Coenzyme A reductase//3-hydroxy-3-methylglutaryl-CoA reductase                                                                                      HMGCR//HMGCR                     3156//3156                     8106280                       90
  3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 (soluble)//3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble)                                                                HMGCS1//HMGCS1                   3157//3157                     8111941                       80
  heme oxygenase (decycling) 1                                                                                                                                                   HMOX1                            3162                           8072678                       10
  heterogeneous nuclear ribonucleoprotein L                                                                                                                                      HNRNPL                           3191                           8036613                       30
  insulin receptor substrate 2                                                                                                                                                   IRS2                             8660                           7972745                       35
  iron-sulfur cluster scaffold homolog (E. coli)                                                                                                                                 ISCU                             23479                          7958414                       100
  interferon stimulated exonuclease gene 20 kDa-like 2                                                                                                                           ISG20L2                          81875                          7921110                       45
  potassium voltage-gated channel, Isk-related fam., member 3                                                                                                                    KCNE3                            10008                          7950409                       25
  keratinocyte growth factor-like protein 1//fibroblast growth factor 7 (keratinocyte growth factor)//keratinocyte growth factor-like protein 2//hypothetical protein FLJ20444   KGFLP1//FGF7//KGFLP2//FLJ20444   387628//2252//654466//403323   8155530                       70
  lysophosphatidic acid receptor 1                                                                                                                                               LPAR1                            1902                           8163257                       10
  leucine-rich PPR-motif containing                                                                                                                                              LRPPRC                           10128                          8051882                       65
  lymphocyte antigen 96                                                                                                                                                          LY96                             23643                          8146934                       35
  mitogen-activated protein kinase kinase 1//small nuclear RNA activating complex, polypeptide 5, 19 kDa                                                                         MAP2K1//SNAPC5                   5604//10302                    7984319                       30
  mitogen-activated protein kinase 13                                                                                                                                            MAPK13                           5603                           8119016                       60
  methyltransferase like 2A                                                                                                                                                      METTL2A                          339175                         8009008                       45
  microsomal glutathione S-transferase 3                                                                                                                                         MGST3                            4259                           7906978                       70
  mitochondrial ribosomal protein L30                                                                                                                                            MRPL30                           51263                          8043848                       30
  mitochondrial ribosomal protein L4                                                                                                                                             MRPL4                            51073                          8025586                       40
  mitochondrial ribosomal protein S17//glioblastoma amplified sequence//zinc finger protein 713                                                                                  MRPS17//GBAS//ZNF713             51373//2631//349075            8132922                       60
  mitochondrial poly(A) polymerase//golgi autoantigen, golgin subfam. a, 6 pseudogene                                                                                            MTPAP//LOC729668                 55149//729668                  7932834                       45
  5-methyltetrahydrofolate-homocysteine methyltransferase                                                                                                                        MTR                              4548                           7910752                       15
  neighbor of BRCA1 gene 1                                                                                                                                                       NBR1                             4077                           8007471                       20
  nuclear import 7 homolog (S. cerevisiae)                                                                                                                                       NIP7                             51388                          7996934                       75
  NLR fam., pyrin domain containing 12                                                                                                                                           NLRP12                           91662                          8039096                       35
  nucleolar protein fam. 6 (RNA-associated)                                                                                                                                      NOL6                             65083                          8160682                       95
  NAD(P)H dehydrogenase, quinone 1                                                                                                                                               NQO1                             1728                           8002303                       45
  nuclear receptor binding protein 1                                                                                                                                             NRBP1                            29959                          8040927                       20
  nucleotide binding protein-like                                                                                                                                                NUBPL                            80224                          7973826                       10
  nudix (nucleoside diphosphate linked moiety X)-type motif 14                                                                                                                   NUDT14                           256281                         7981566                       35
  nuclear fragile × mental retardation protein interacting protein 1                                                                                                             NUFIP1                           26747                          7971361                       60
  nucleoporin 153 kDa                                                                                                                                                            NUP153                           9972                           8124059                       25
  olfactory receptor, fam. 5, subfam. B, member 21                                                                                                                               OR5B21                           219968                         7948330                       50
  PAS domain containing serine/threonine kinase                                                                                                                                  PASK                             23178                          8060205                       55
  PRKC, apoptosis, WT1, regulator                                                                                                                                                PAWR                             5074                           7965112                       30
  PDGFA associated protein 1                                                                                                                                                     PDAP1                            11333                          8141273                       35
  phosphodiesterase 1B, calmodulin-dependent                                                                                                                                     PDE1B                            5153                           7955943                       85
  phosphoribosylformylglycinamidine synthase                                                                                                                                     PFAS                             5198                           8004804                       60
  pleckstrin homology-like domain, fam. A, member 3                                                                                                                              PHLDA3                           23612                          7923372                       75
  phosphoinositide-3-kinase adaptor protein 1                                                                                                                                    PIK3AP1                          118788                         7935337                       20
  PTEN induced putative kinase 1                                                                                                                                                 PINK1                            65018                          7898663                       70
  phosphomannomutase 2                                                                                                                                                           PMM2                             5373                           7993148                       65
  partner of NOB1 homolog (S. cerevisiae)                                                                                                                                        PNO1                             56902                          8042381                       40
  polymerase (RNA) II (DNA directed) polypeptide E, 25 kDa                                                                                                                       POLR2E                           5434                           8032149                       80
  polymerase (RNA) III (DNA directed) polypeptide E (80 kD)                                                                                                                      POLR3E                           55718                          7993973                       30
  protein phosphatase 1D magnesium-dependent, delta isoform//protein phosphatase, Mg2+/Mn2+ dependent, 1D                                                                        PPM1D//PPM1D                     8493//8493                     8008922                       80
  phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1                                                                                                       PREX1                            57580                          8066848                       100
  proline-serine-threonine phosphatase interacting protein 1                                                                                                                     PSTPIP1                          9051                           7985099                       95
  prothymosin, alpha                                                                                                                                                             PTMA                             5757                           7954006 and 7961022           20 and 15
  RAB33B, member RAS oncogene fam.                                                                                                                                               RAB33B                           83452                          8097507                       40
  renin binding protein                                                                                                                                                          RENBP                            5973                           8175933                       65
  replication factor C (activator 1) 2, 40 kDa                                                                                                                                   RFC2                             5982                           8140151                       30
  ribonuclease H1                                                                                                                                                                RNASEH1                          246243                         8050079                       90
  ring finger protein 146                                                                                                                                                        RNF146                           81847                          8121927                       50
  ring finger protein 24                                                                                                                                                         RNF24                            11237                          8064766                       100
  ring finger protein 26                                                                                                                                                         RNF26                            79102                          7944510                       95
  ribosomal protein SA//small nucleolar RNA, H/ACA box 62                                                                                                                        RPSA//SNORA62                    3921//6044                     8078918                       75
  RNA pseudouridylate synthase domain containing 2                                                                                                                               RPUSD2                           27079                          7982753                       45
  ribosomal RNA processing 12 homolog (S. cerevisiae)                                                                                                                            RRP12                            23223                          7935425                       75
  retinoid × receptor, alpha                                                                                                                                                     RXRA                             6256                           8159127                       5
  scavenger receptor class B, member 2                                                                                                                                           SCARB2                           950                            8101158                       70
  SERPINE1 mRNA binding protein 1                                                                                                                                                SERBP1                           26135                          7916836                       95
  splicing factor proline/glutamine-rich (polypyrimidine tract binding protein associated)//splicing factor proline/glutamine-rich                                               SFPQ//SFPQ                       6421//6421                     7914791                       40
  solute carrier fam. 25, member 32//DDB1 and CUL4 associated factor 13                                                                                                          SLC25A32//DCAF13                 81034//25879                   8152255                       100
  solute carrier fam. 35, member B3                                                                                                                                              SLC35B3                          51000                          8123825                       40
  solute carrier fam. 37 (glucose-6-phosphate transporter), member 4                                                                                                             SLC37A4                          2542                           7952132                       55
  solute carrier fam. 5 (sodium-dependent vitamin transporter), member 6                                                                                                         SLC5A6                           8884                           8051030                       95
  sphingomyelin phosphodiesterase 4, neutral membrane (neutral sphingomyelinase-3)                                                                                               SMPD4                            55627                          8055183                       40
  small nucleolar RNA host gene 1 (non-protein coding)//small nucleolar RNA, C/D box 26                                                                                          SNHG1//SNORD26                   23642//9302                    7948908                       20
  small nucleolar RNA host gene 12 (non-protein coding)                                                                                                                          SNHG12                           85028                          7914202                       10
  small nucleolar RNA, H/ACA box 45                                                                                                                                              SNORA45                          677826                         7938293                       25
  sorting nexin fam. member 27                                                                                                                                                   SNX27                            81609                          7905444                       35
  spinster homolog 2 (Drosophila)//MYB binding protein (P160) 1a                                                                                                                 SPNS2//MYBBP1A                   124976//10514                  8011640                       45
  sprouty homolog 2 (Drosophila)                                                                                                                                                 SPRY2                            10253                          7972217                       75
  squalene epoxidase                                                                                                                                                             SQLE                             6713                           8148280                       95
  sterol regulatory element binding transcription factor 2                                                                                                                       SREBF2                           6721                           8073522                       45
  ST3 beta-galactoside alpha-2,3-sialyltransferase 6                                                                                                                             ST3GAL6                          10402                          8081219                       100
  serine/threonine kinase 17b                                                                                                                                                    STK17B                           9262                           8057887                       90
  transmembrane anterior posterior transformation 1                                                                                                                              TAPT1                            202018                         8099506                       65
  taste receptor, type 2, member 5                                                                                                                                               TAS2R5                           54429                          8136647                       40
  tubulin folding cofactor E-like                                                                                                                                                TBCEL                            219899                         7944623                       55
  tectonic fam. member 2                                                                                                                                                         TCTN2                            79867                          7959638                       40
  toll-like receptor 6                                                                                                                                                           TLR6                             10333                          8099841                       30
  transmembrane protein 150B                                                                                                                                                     TMEM150B                         284417                         8039453                       25
  transmembrane protein 55A                                                                                                                                                      TMEM55A                          55529                          8151756                       90
  transmembrane protein 59                                                                                                                                                       TMEM59                           9528                           7916372                       90
  transmembrane protein 97                                                                                                                                                       TMEM97                           27346                          8005839                       95
  tumor necrosis factor receptor superfam., member 10c, decoy without an intracellular domain                                                                                    TNFRSF10C                        8794                           8145244                       75
  translocase of outer mitochondrial membrane 34                                                                                                                                 TOMM34                           10953                          8066461                       35
  translocase of outer mitochondrial membrane 40 homolog (yeast)                                                                                                                 TOMM40                           10452                          8029521                       40
  tumor protein p53 inducible protein 3                                                                                                                                          TP53I3                           9540                           8050702                       30
  tumor protein p53 inducible nuclear protein 1                                                                                                                                  TP53INP1                         94241                          8151890                       100
  twinfilin, actin-binding protein, homolog 2 (Drosophila)//toll-like receptor 9                                                                                                 TWF2//TLR9                       11344//54106                   8087860                       65
  thioredoxin reductase 1                                                                                                                                                        TXNRD1                           7296                           7958174                       55
  ubiquitin-fold modifier conjugating enzyme 1                                                                                                                                   UFC1                             51506                          7906662                       95
  ubiquitin specific peptidase 10                                                                                                                                                USP10                            9100                           7997633                       30
  vesicle-associated membrane protein 3 (cellubrevin)                                                                                                                            VAMP3                            9341                           7897370                       40
  valyl-tRNA synthetase                                                                                                                                                          VARS                             7407                           8125091 and 8178609           10 and 10
  vacuolar protein sorting 37 homolog A (S. cerevisiae)                                                                                                                          VPS37A                           137492                         8144774                       60
  zinc finger protein 211                                                                                                                                                        ZNF211                           10520                          8031792                       45
  zinc finger protein 223                                                                                                                                                        ZNF223                           7766                           8029360                       65
  zinc finger protein 561                                                                                                                                                        ZNF561                           93134                          8033795                       60
  zinc finger protein 79                                                                                                                                                         ZNF79                            7633                           8158022                       100
  \-\--                                                                                                                                                                          \-\--                            \-\--                          7910385                       40
  \-\--                                                                                                                                                                          \-\--                            \-\--                          7946567                       15
  \-\--                                                                                                                                                                          \-\--                            \-\--                          7966223                       45
  \-\--                                                                                                                                                                          \-\--                            \-\--                          7979694                       40
  \-\--                                                                                                                                                                          \-\--                            \-\--                          8130495                       30
  \-\--                                                                                                                                                                          \-\--                            \-\--                          8180237                       60
  \-\--                                                                                                                                                                          \-\--                            \-\--                          8180268                       85
  \-\--                                                                                                                                                                          \-\--                            \-\--                          8180417                       85

The table shows the biomarker genes found by t-test and Backward Elimination. Genes were annotated, using the NetAffx database from Affymetrix (<http://www.affymetrix.com>, Santa Clara USA). When found, the Entrez Gene ID <http://www.ncbi.nlm.nih.gov/gene> was chosen as the gene identifier. The validation call frequency (%) is the occurrence of each gene in the 20 Test Gene Signatures obtained in the validation step.

![**Transcriptional profiles of sensitizers and non-sensitizers**. Hierarchical clustering of the genes in the Prediction Signature. Samples are grouped as sensitizer or non-sensitizer, and all replicates are included. Each row represents one gene, which is scaled to have a mean of zero and standard deviation of one, with colors representing the number of standard deviations from the mean.](1471-2164-12-399-5){#F5}

Interrogation of the analysis used to identify the Prediction Signature
-----------------------------------------------------------------------

To validate the predictive power of our signature, we used a machine learning method called the Support Vector Machine (SVM) \[[@B12]\], which maps the data from a training set in space in order to maximize the separation of gene expression induced by sensitizing and non-sensitizing chemicals. As training set, 70% of the data set was selected randomly and the entire selection process was repeated. Starting with 29,141 transcripts, the signature was reduced to 200 transcripts, termed \"Test Gene Signature\", using ANOVA filtering and backward elimination, as described above. The remaining 30% of the data set was used to test each signature. The partitioning of the data set into subsets of 70% training data set and 30% test data set was done in a stratified random manner, while maintaining the relation of sensitizers and non-sensitizers. Thereafter, the Test Gene Signature was used to train an SVM model with the training set, and the predictive power of the model was assessed with the test set. This entire process was iterated 20 times. The frequency by which each gene in the Prediction Signature was included in the Test Gene Signatures is reported in table [1](#T1){ref-type="table"}. Figure [6A](#F6){ref-type="fig"} shows a PCA plot based on the Test Gene Signature from one representative iteration. Clearly, the separation between sensitizers and non-sensitizers resembles the one observed for the Prediction Signature in Figure [4B](#F4){ref-type="fig"}. In Figure [6A](#F6){ref-type="fig"}, the samples of the sensitizing and non-sensitizing chemicals in the test set have been colored dark red and dark green respectively, indicating that they are not contributing to the principal components of the plot, but are merely plotted based on their expression values of the selected Test Gene Signature. As can be seen, sensitizers from the test set group with sensitizers from the training set, while non-sensitizers from the test set group with non-sensitizers from the training set. The final outcome of the SVM training and validation can be seen in Figure [6B](#F6){ref-type="fig"}, where the areas under the ROC curve are plotted for each iteration. The average area under the ROC curve of 0.98 confirms the ability to discriminate sensitizers from control samples. Based on this average, the estimated prediction performance of the assay reveals an accuracy of 99%, sensitivity of 99% and specificity of 99%. While this experiment does not validate the prediction power of the Prediction Signature *per se*, it does indeed validate the method by which it has been selected, supporting the claim that the Prediction Signature is capable of accurately predicting sensitizing properties of unknown samples.

![**Validation of selection procedure of Prediction Signature**. The method by which the Prediction Signature was constructed was validated by repeating the process on 70% randomly selected data (training set). The remaining 30% of data was used as a test set for signature validation. The process was repeated for 20 iterations. A) A representative PCA of one of the 20 iterations, which demonstrates that the Test Gene Signature can separate skin sensitizers from non-sensitizers. Only the samples of the 70% training set, displayed in bright colors, were used to build the space of the first three principal components. The test set samples, displayed in dark colors, were plotted into this space based on expression levels of the analytes in the Test Gene Signature. B) An SVM was trained on the 70% training set, and validated with the 30% test set. The areas under the ROC curve from 20 such randomizations are plotted, yielding an average AUC value of 0.98. This indicated that the classification of samples in the test set was correct.](1471-2164-12-399-6){#F6}

Interactome, molecular functions and canonical pathways involving the Prediction Signature
------------------------------------------------------------------------------------------

Using Ingenuity Pathways Analysis (IPA, Ingenuity Systems Inc.), 184 of the 200 molecules in the signature were characterized with regard to the interactome, known functions and (canonical) pathways. The remaining 16 molecules could not be mapped to any unique IPA entries. The dominating functions identified were small molecule biochemistry (39 molecules), cell death (33), lipid metabolism (25), hematological system development (18), cell cycle (18), molecular transport (17), cellular growth and proliferation (16), and carbohydrate metabolism (15) (Table [2](#T2){ref-type="table"}).

###### 

Dominating functions of the Prediction signature

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Function                            Number of molecules from signature   Molecule names                                                                                                                                                                                                                                                                           Most prominent sub functions
  ----------------------------------- ------------------------------------ ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------
  small molecule biochemistry         39                                   ABHD5, ACLY, ALDH18A1, BLMH, CD86, CSGALNACT2, CYP51A1, DHCR24, DHCR7, DNAJC5, FAS, FASN, FDXR, FOXO4, GLRX, GNPNAT1, HMGCR, HMOX1, IRS2, LPAR1, LY96, MGST3, MTR, NQO1, PASK, PDE1B, PINK1, PMM2, RENBP, RXRA, SLC25A32, SLC37A4, SLC5A6, SMPD4, SQLE, SREBF2, ST3GAL6, TLR6, TMEM55A   Metabolism (24), biosynthesis (15), modification (12), synthesis (11)

                                                                                                                                                                                                                                                                                                                                                                    

  cell death                          33                                   CD33, DDX19A, DHCR24, DNAJB9, DNAJC5, FAS, FASN, FDXR, FOXO4, GLRX, GNPNAT1, GSR, HIST1H1C, HMGB3, HMOX1, IRS2, LPAR1, MAP2K1, MAPK13, NQO1, PAWR, PDE1B, PHLDA3, PINK1, PPM1D, RXRA, SERBP1, SPRY2, STK17B, TLR6, TNFRSF10C, TP53INP1, TXNRD1                                           Apoptosis (30), cell death (13)

                                                                                                                                                                                                                                                                                                                                                                    

  lipid metabolism                    25                                   ABHD5, ACLY, CYP51A1, DHCR24, DHCR7, FAS, FASN, FDXR, FOXO4, HMGCR, HMOX1, IRS2, LPAR1, LY96, MGST3, PASK, RENBP, RXRA, SLC37A4, SMPD4, SQLE, SREBF2, ST3GAL6, TLR6, TMEM55A                                                                                                             Metabolism (18),\
                                                                                                                                                                                                                                                                                                                                                                    synthesis (11), modification (11)

                                                                                                                                                                                                                                                                                                                                                                    

  hematological system development    18                                   CARM1, CD33, CD86, FAS, FOXO4, HMGB3, HMGCR, HMOX1, IRS2, LY96, NBR1, NQO1, PAWR, PIK3AP1, PPM1D, STK17B, TP53INP1, VAMP3                                                                                                                                                                Proliferation (10),\
                                                                                                                                                                                                                                                                                                                                                                    quantity (7)

                                                                                                                                                                                                                                                                                                                                                                    

  cell cycle                          18                                   ABHD5, ANAPC5, DNAJB4, DTD1, FAS, FASN, FOXO4, GDF11, HBP1, HMOX1, IRS2, MAP2K1, PAWR, PPM1D, RXRA, SFPQ, SPRY2, TP53INP1                                                                                                                                                                Cell cycle progression (13), G2 phase (5)

                                                                                                                                                                                                                                                                                                                                                                    

  molecular transport                 17                                   ABHD5, DNAJC5, FAS, FOXO4, HMOX1, LPAR1, MTR, NQO1, PASK, PINK1, RENBP, RXRA, SLC25A32, SLC37A4, SLC5A6, SREBF2, TLR6                                                                                                                                                                    Accumulation (9), quantity (5)

                                                                                                                                                                                                                                                                                                                                                                    

  cellular growth and proliferation   16                                   CD33, CD86, FAS, GNPNAT1, HMOX1, IRS2, LPAR1, LY96, MAP2K1, PAWR, PIK3AP1, PPM1D, RXRA, SPRY2, STK17B, TP53INP1                                                                                                                                                                          Proliferation (16), growth (4)

                                                                                                                                                                                                                                                                                                                                                                    

  carbohydrate metabolism             15                                   ABHD5, ACLY, CSGALNACT2, FAS, FASN, FUCA2, GNPNAT1, IRS2, LY96, NQO1, PMM2, RENBP, SLC37A4, ST3GAL6, TMEM55A                                                                                                                                                                             Metabolism (9), biosynthesis (5)
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Dominating functions in the molecular signature. 184 of the 200 molecules were functionally investigated, using IPA. Only functions populated by 15 or more genes were included in the present study.

Pathways possibly invoked by the molecules in the signature were also investigated using IPA. Those most highly populated involved NRF2-mediated oxidative response (10), xenobiotic metabolism signaling (8), protein ubiquitination pathway (7), LPS/IL-1 mediated inhibition of RXR function (6), aryl hydrocarbon receptor signaling (6) and protein kinase A signaling (6). These pathways are known to take part in reactions provoked by foreign substances, xenobiotics, which supports a relevant biology behind the genomic signature.

Discussion
==========

Allergic contact dermatitis (ACD) is an inflammatory skin disease caused by an adaptive immune response to normally innocuous chemicals \[[@B13]\]. Small molecular weight chemicals, so-called haptens, can bind self-proteins in the skin, which enables internalization of the protein-bound allergenic chemical by skin dendritic cell (DC). DCs, under the influence of the local microenvironment, process the protein-hapten complex, migrate to the local lymph nodes and activate naïve T cells. The initiation and development of allergen-specific responses, mainly effector CD8+ T cells and Th1 cells, and production of immunoregulatory proteins, are hallmarks of the immune activation observed in ACD. ACD is also the most common manifestation of immunotoxicity observed in humans \[[@B13]\] and hundreds of chemicals have been shown to cause sensitization in skin \[[@B14]\]. The driving factors and molecular mechanisms involved in sensitization are still unknown even though intense research efforts have been carried out to characterize the immunological responses towards allergenic chemicals. The REACH legislation requires that all chemicals produced over 1 ton/year are tested for hazardous properties such as toxicity and allergenicity \[[@B5]\], which increase the demand for accurate assays with predictive power for hazard identification. Additionally, the 7th Amendment to the Cosmetics Directive (76/768/EEC) poses a complete ban on using animal experimentation for testing cosmetic ingredients by 2013 if a scientifically reliable method is available. Thus, there is a significant need for predictive test methods that are based on human cells. Today, the identification of potential human sensitizers relies on animal experimentation, in particular the murine local lymph node assay (LLNA) \[[@B6]\]. The LLNA is based upon measurements of proliferation induced in draining lymph nodes of mice after chemical exposure \[[@B15]\]. Chemicals are defined as sensitizers if they provoke a three-fold increase in proliferation compared to control, and the amount of chemical required for the increase is the EC3 value. Thus, the LLNA can also be used to categorize the chemicals based on sensitization potency. However, LLNA is, besides the obvious ethical implications, also time consuming and expensive. Human sensitization data often stem from human maximization tests (HMT) \[[@B16]\] and human patch tests (HPT). In an extensive report from the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM), the performance characteristics of LLNA were compared to other available animal-based methods and human sensitization data (HMT and HPT) \[[@B17]\]. The LLNA performance in comparison to human data (74 assessments) revealed an accuracy of 72%, a sensitivity of 72% and a specificity of 67%.

Various human cell lines and primary cells involved in sensitization have been evaluated as predictive test system, such as epithelial cells, dendritic cells and T cells, however, no validated test assay is currently available. THP-1, U937, KG-1 and MUTZ-3, naive or differentiated, are among the human myeloid cell lines most extensively evaluated as platforms for DC-based in vitro assays, as reviewed in \[[@B18]\]. These cells are easy to grow and enable standardization of protocols. U937 and THP-1 are currently being evaluated in pre-validation stage for prediction of skin sensitization. The Human Cell Line Activation Test (hCLAT) is based upon analysis of CD86 and/or CD54 expression on THP-1 cells after chemical stimulation \[[@B19],[@B20]\]. The Myeloid U937 Skin Sensitization Test (MUSST) also involves analysis of CD86 \[[@B21]\]. These assays are thus very limited in readout. As CD86 is among the markers most extensively studied, we evaluated the expression level of this marker in our assay. We demonstrated its relevance but also its insufficient predictive power (Figure [2](#F2){ref-type="fig"}), since only 10 out of 20 sensitizing chemicals induced a significant up regulation of CD86. Various other single biomarkers have been suggested to be up regulated upon stimulation with sensitizing chemicals, such as CD40, CD80, CD54, CXCL8, IL-1β, MIP-1β, p38 MAPK, as reviewed in \[[@B18]\], yet single-handedly, none of them have enough predictive power to discriminate between sensitizing and non-sensitizing chemicals. The analysis of biomarker signatures, i.e. combination of biomarkers, has been shown to be superior in molecular diagnostic of cancer and superior to any single biomarker. Consequently, we therefore utilized the power of global transcriptomics and screened the gene regulation induced by a large set of well-defined chemicals and controls in search of predictive biomarker combinations.

The large number of differentially expressed genes in MUTZ-3 cells stimulated with sensitizing chemicals vs. non-sensitizing controls revealed that MUTZ-3 indeed had a capacity to differentiate between these two groups. Efforts have previously been done to create assays based on genome analysis in various cell systems, such as e.g. CD34^+^-progenitor cells-derived DCs \[[@B22]-[@B24]\]. While such assays might provide in vivo like environments, primary cells are not well suited for a high-throughput format considering both donor-dependent variations as well as ethical aspect of such cell sources. Furthermore, previous efforts within in vitro assay development for sensitization that rely on full genome analysis have used a limited set of testing compounds.

The present study utilized in all 40 compounds and efforts were made to divide these compounds into two subsets, for training and testing respectively. While these experiments have resulted in successful predictions (data not shown), it is our experience that sensitizing compounds differ greatly in their induced gene expression profile, as can be seen in Figure [3D](#F3){ref-type="fig"}. In this perspective, we strived to include as many training compounds as possible when identifying our Prediction Signature, and did not exclude any compounds for validation. Instead, we validated the method by which the Prediction Signature was identified, by subdividing the samples into training and test sets at random, using unseen data for validation, to avoid overfitting. At present, the Prediction Signature consists of 200 transcripts, based on Figure [4A](#F4){ref-type="fig"}. Continuing the elimination process beyond 200 transcripts causes loss of information, as seen by the rise of KLD. Experiments have shown that correct classifications are possible even with further reduced signatures, down to 11 genes (data not shown). A reduction of signature size could be assessed in conjunction with validation of the assay, using untested positive and negative compounds in a new test set. By reducing the signature size at this point, the risk of biasing the signature towards this data set increases, making it harder to correctly classify unknown samples. Additional test compounds will also serve to assess the frequency of extreme transcriptional profile outliers, such as Oxazolone and Cinnamic aldehyde, which had to be removed from the analysis performed in this study. A number of reasons may be attributed to the fact that these compounds were not compatible with the assay, such as solubility in the cell media or extreme toxic effects. In those cases, other in vitro alternatives may complement this assay, so that the safety assessment of chemicals for sensitization includes a battery of in vitro assays. Naturally, an additional data set with blinded compounds is essential to validate whether the assay truly performs as estimated by the random subdivisions into training and test sets.

Of note, our Prediction Signature is able to predict the potency of sensitizing compounds, as defined by the LLNA (Figure [4C](#F4){ref-type="fig"}). However, the potency predicted by LLNA and that of our classifier do not match for all samples. Notably, the moderate sensitizer 2-hydroxyethyl acrylate showed resemblance to strong and extreme sensitizers with respect to gene expression profile. Similarly, the moderate sensitizers ethylendiamine, hexylcinnamic aldehyde, and glyoxal grouped together with weak sensitizers. These findings support the fact that sensitizing potency, as defined, may need revising.

By studying the identity of the transcripts and their involvement in intracellular signaling pathways, we were also able to confirm the biological relevance of the Prediction Signature. Using IPA, we found that the most highly populated pathways were nuclear factor-erythroid 2-related factor 2 (NRF2) mediated oxidative response, xenobiotic metabolism signaling, protein ubiquitination pathway, LPS/IL-1 mediated inhibition of Retinoic X receptor (RXR) function, aryl hydrocarbon receptor (AHR) signaling, and protein kinase A (PKA) signaling. These pathways are all known to take part in reactions provoked by xenobiotics, and several were associated with oxidative stress. Furthermore, Toll-like receptor (TLR) signaling is among the top pathways found in IPA. Recent studies on assay development for prediction of sensitization in vitro have to a large extent focused on how danger signals are provided to antigen-presenting cells, inducing pro-inflammatory cytokines and chemokines, as well as co-stimulatory molecules needed for a specific T-cell response. We hypothesize that these signals are provided through the innate immune responses, in analogy with infections, as reviewed in \[[@B25]\].

The primary pathways found in this study involved NRF2 signaling. This is a pathway activated by Reactive Oxygen Species (ROS), and is a defense mechanism to xenobiotics and response to cellular stress. In the resting cell, NRF2 is bound by kelch-like ECH-associated protein 1 (KEAP1) and located in the cytosol. In the response to ROS activity, KEAP1 is targeted for ubiquitination and protesomal degradation, resulting in the translocation of NRF2 to the nucleus, where it activates transcription of genes containing anti-oxidant response elements (ARE) in their promoter region \[[@B26]\]. The functions of genes transcribed by NRF2 association to ARE include regulation of inflammation, migration of DC and anti-oxidant defense enzymes, such as NADPH quinone oxidoreductase 1 (NQO1) and glutathione S-transferases (GST) \[[@B27],[@B28]\], genes found in the Prediction Signature. Furthermore, the NRF2/KEAP1/ARE pathway has previously been described as activated in response to skin sensitizers, inducing maturation of dendritic cells \[[@B29]\].

Similarly, AHR is a transcription factor in the cytosol that is activated by binding to ligands, which includes a wide range of xenobiotic chemicals, such as halogenated aromatic hydrocarbons, polyphenols and a number of pharmaceuticals \[[@B30]\]. In the absence of a ligand, AHR is bound by a complex of chaperon proteins, keeping it in the cytosol. Upon ligand binding, AHR is translocated to the nucleus, where it dimerizes with aryl hydrocarbon receptor nuclear translocator (ARNT) \[[@B30]\]. The ARNT/AHR heterodimer then binds to xenobiotic response elements (XRE) in promoter regions of target genes. The typical target genes for XRE include enzymes for drug metabolism, such as the cytochrome P450 (CYP) superfamily, as well as cytoprotective enzymes mediating defense against oxidative stress, such as NQO1 \[[@B31]\]. Interestingly, while NQO1 is under control of both NRF2 and AHR, with both ARE and XRE in the promoter region, it has also been shown that AHR is among the target genes for the activated NRF2 pathway and vice versa \[[@B32]\]. Thus, a battery of protective enzymes are induced in response to a variety of xenobiotics, possibly through a number of signaling pathways, ultimately leading to the maturation of dendritic cells, as also indicated by the present data. The protein ubiquitination pathway is involved in degradation of short-lived or regulatory proteins involved in many cellular processes, such as the cell cycle, cell proliferation, apoptosis, DNA repair, transcription regulation, cell surface receptors and ion channels regulation, and antigen presentation. Of note, both NRF2 and AHR are in the resting cell bound by proteins that are targeted for ubiquitination upon ligand binding.

RXR is a nuclear receptor, with retinoic acid as the most prominent natural ligand \[[@B33]\]. It has previously been described as important for xenobiotics recognition and glutathione homeostasis, with cytoprotective enzymes as target genes \[[@B34],[@B35]\].

TLR signaling is known to play a major role in dendritic cell maturation, as they activate transcription of a number of pro-inflammatory cytokines, chemokine-receptors for homing to lymph nodes and co-stimulatory molecules \[[@B36]-[@B38]\]. While TLR6 and TLR9 are present in our Prediction Signature, others have reported TLR4 as a crucial mediator of contact allergy to nickel \[[@B39]\]. As these receptors all signal through nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), it is not surprising that different compounds activate different receptors, considering the chemical diversity of skin sensitizers, as discussed above.

Lastly, PKA signaling is a vastly versatile pathway activated by numerous stimuli, and, to the best of knowledge, this pathway has not previously been reported in association with skin sensitization. However, individual species of CYPs are known to be phosphorylated by PKA, in response to elevated levels of cyclic adenosine monophosphate (cAMP), triggered by xenobiotics. In addition, cAMP levels influence the nuclear translocation of AHR, connecting these two pathways and their impact on CYP activity \[[@B40]\].

Conclusion
==========

In this paper, we have demonstrated the predictive power of a genomic biomarker signature, which correctly classifies sensitizers and non-sensitizers. The biomarker signature was derived from the human DC-like cell line MUTZ-3, which was challenged with a panel of 40 reference chemical compounds. The biomarker genes were shown to be biologically relevant, as demonstrated by their involvement in cytoprotective mechanisms and pathways triggered by xenobiotic substances, supporting their relevance as predictor genes for skin sensitization. The findings reported in this paper might impact the development of in vitro assays for assessment of skin sensitization, which is crucial in order to replace the animal models currently in use.

Methods
=======

Chemicals
---------

A panel of 40 chemical compounds, consisting of 20 sensitizers and 20 non-sensitizers were used for cell stimulations. The sensitizers were 2,4-dinitrochlorobenzene, cinnamaldehyde, resorcinol, oxazolone, glyoxal, 2-mercaptobenzothiazole, eugenol, isoeugenol, cinnamic alcohol, *p*-phenylendiamine, formaldehyde, ethylendiamine, 2-hydroxyethyl acrylate, hexylcinnamic aldehyde, potassium dichromate, penicillin G, kathon CG (MCI/MI), 2-aminophenol, geraniol and 2-nitro-1,4-phenylendiamine. The non-sensitizers were sodium dodecyl sulphate, salicylic acid, phenol, glycerol, lactic acid, chlorobenzene, *p*-hydrobenzoic acid, benzaldehyde, diethyl phtalate, octanoic acid, zinc sulphate, 4-aminobenzoic acid, methyl salicylate, ethyl vanillin, isopropanol, dimethyl formamide, 1-butanol, potassium permanganate, propylene glycol and tween 80 (Table [3](#T3){ref-type="table"}). All chemicals were from Sigma-Aldrich, St. Louis, MO, USA. Compounds were dissolved in either dimethyl sulfoxide (DMSO) or distilled water. Prior to stimulations, the cytotoxicity of all compounds was monitored, using propidium iodide (PI) (BD Biosciences, San Diego, CA) using protocol provided by the manufacturer. The relative viability of stimulated cells was calculated as

###### 

List of reference chemicals used in assay development

  Compound                      Abbreviation   Potency                     LLNA                     HMT^1^   HPTA^1^
  ----------------------------- -------------- --------------------------- ------------------------ -------- ---------
  ***Sensitizers***                                                                                          
  2,4-Dinitrochlorobenzene      DNCB           Extreme \[[@B15]\]          \+ \[[@B15]\]                     
  Oxazolone                     OXA            Extreme \[[@B15]\]          \+ \[[@B15]\]                     
  Potassium dichromate          PD             Extreme \[[@B14]\]          \+ \[[@B14]\]            \+       \+
  Kathon CG (MC/MCI)            KCG            Extreme \[[@B14],[@B45]\]   \+ \[[@B14],[@B46]\]              
  Formaldehyde                  FA             Strong \[[@B15]\]           \+ \[[@B15]\]            \+       \+
  2-Aminophenol                 2AP            Strong \[[@B46]\]           \+ \[[@B47]\]                     
  2-nitro-1,4-Phenylendiamine   NPDA           Strong \[[@B46]\]           \+ \[[@B47]\]                     
  p-Phenylendiamine             PPD            Strong \[[@B47]\]           \+ \[[@B48]\]            \+       \+
  Hexylcinnamic aldehyde        HCA            Moderate \[[@B15]\]         \+ \[[@B15]\]                     
  2-Hydroxyethyl acrylate       2HA            Moderate \[[@B46]\]         \+ \[[@B47]\]                     \+
  2-Mercaptobenzothiazole       MBT            Moderate \[[@B46]\]         \+ \[[@B47]\]            \+       \+
  Glyoxal                       GO             Moderate \[[@B46]\]         \+ \[[@B47]\]            \+       
  Cinnamaldehyde                CALD           Moderate \[[@B47]\]         \+ \[[@B48]\]            \+       \+
  Isoeugenol                    IEU            Moderate \[[@B47]\]         \+ \[[@B48]\]                     \+
  Ethylendiamine                EDA            Moderate \[[@B14]\]         \+ \[[@B14]\]                     
  Resorcinol                    RC             Moderate \[[@B48]\]         \+ \[[@B49]\]            \-       \+
  Cinnamic alcohol              CALC           Weak \[[@B46]\]             \+ \[[@B48]\]                     
  Eugenol                       EU             Weak \[[@B47]\]             \+ \[[@B48]\]                     \+
  Penicillin G                  PEN G          Weak \[[@B47]\]             \+ \[[@B48]\]            \+       
  Geraniol                      GER            Weak \[[@B14]\]             \+ \[[@B14]\]            \-       \+
  ***Non-sensitizers***                                                                                      
  1-Butanol                     BUT                                        \- \[[@B50]\]                     
  4-Aminobenzoic acid           PABA                                       \- \[[@B51]\]            \-       \+
  Benzaldehyde                  BA                                         \- \[[@B52]\]                     
  Chlorobenzene                 CB                                         \- \[[@B14]\]                     
  Diethyl phthalate             DP                                         \- \[[@B48]\]                     
  Dimethyl formamide            DF                                         \- \[[@B46]\]                     
  Ethyl vanillin                EV                                         \- \[[@B52]\]                     
  Glycerol                      GLY                                        \- \[[@B48]\]                     
  Isopropanol                   IP                                         \- \[[@B48]\]                     
  Lactic acid                   LA                                         \- \[[@B14]\]                     
  Methyl salicylate             MS                                         \- \[[@B14]\]            \-       
  Octanoic acid                 OA                                         \- \[[@B53]\]                     
  Propylene glycol              PG                                         \- \[[@B51]\]                     
  Phenol                        PHE                                        \- \[[@B53]\]            \-       
  p-Hydroxybenzoic acid         HBA                                        \- \[[@B54]\]                     
  Potassium permanganate        PP                                         \-                                
  Salicylic acid                SA                                         \- \[[@B14]\]            \-       
  Sodium dodecyl sulphate       SDS                                        \+^2^\[[@B14],[@B53]\]   \-       
  Tween 80                      T80                                        \- \[[@B20]\]                     \+
  Zinc sulphate                 ZS                                         \+^2^\[[@B55]\]                   

List of sensitizers and non-sensitizers used in assay development. 1) HMT, Human Maximization Test; HPTA, Human Patch Test Allergen. Information is derived from \[[@B17]\]. 2) False positives in LLNA.

For toxic compounds, the concentration yielding 90% relative viability (Rv90) was used. For non-toxic compounds, a concentration of 500 μM was used. For non-toxic compounds that were insoluble at 500 μM in medium, the highest soluble concentration was used. For compounds dissolved in DMSO, the final concentration of DMSO in each well was 0.1%. The vehicle and concentrations used for each compound are listed in Table [4](#T4){ref-type="table"}.

###### 

Concentrations and vehicles used for each reference chemical

  ----------------------------------------------------------------------------------------------------
  Compound                      Abbreviation   Vehicle   Max solubility\   Rv90\     Concentration\
                                                         (μM)              (μM)      in culture (μM)
  ----------------------------- -------------- --------- ----------------- --------- -----------------
  ***Sensitizers***                                                                  

  2,4-Dinitrochlorobenzene      DNCB           DMSO      \-                4         4

  Oxazolone                     OXA            DMSO      250               \-        250

  Potassium dichromate          PD             Water     51.02             1.5       1.5

  Kathon CG (MC/MCI)^1^         KCG            Water     \-                0.0035%   0.0035%

  Formaldehyde                  FA             Water     \-                80        80

  2-Aminophenol                 2AP            DMSO      \-                100       100

  2-nitro-1,4-Phenylendiamine   NPDA           DMSO      \-                300       300

  p-Phenylendiamine             PPD            DMSO      566               75        75

  Hexylcinnamic aldehyde        HCA            DMSO      32.34             \-        32.24

  2-Hydroxyethyl acrylate       2HA            Water     \-                100       100

  2-Mercaptobenzothiazole       MBT            DMSO      250               \-        250

  Glyoxal                       GO             Water     \-                300       300

  Cinnamaldehyde                CALD           Water     \-                120       120

  Isoeugenol                    IEU            DMSO      641               300       300

  Ethylendiamine                EDA            Water     \-                \-        500

  Resorcinol                    RC             Water     \-                \-        500

  Cinnamic alcohol              CALC           DMSO      500               \-        500

  Eugenol                       EU             DMSO      649               300       300

  Penicillin G                  PEN G          Water     \-                \-        500

  Geraniol                      GER            DMSO      \-                \-        500

  ***Non-sensitizers***                                                              

  1-Butanol                     BUT            DMSO      \-                \-        500

  4-Aminobenzoic acid           PABA           DMSO      \-                \-        500

  Benzaldehyde                  BA             DMSO      250               \-        250

  Chlorobenzene                 CB             DMSO      98                \-        98

  Diethyl phthalate             DP             DMSO      50                \-        50

  Dimethyl formamide            DF             Water     \-                \-        500

  Ethyl vanillin                EV             DMSO      \-                \-        500

  Glycerol                      GLY            Water     \-                \-        500

  Isopropanol                   IP             Water     \-                \-        500

  Lactic acid                   LA             Water     \-                \-        500

  Methyl salicylate             MS             DMSO      \-                \-        500

  Octanoic acid                 OA             DMSO      504               \-        500

  Propylene glycol              PG             Water     \-                \-        500

  Phenol                        PHE            Water     \-                \-        500

  p-Hydroxybenzoic acid         HBA            DMSO      250               \-        250

  Potassium permanganate        PP             Water     38                \-        38

  Salicylic acid                SA             DMSO      \-                \-        500

  Sodium dodecyl sulphate       SDS            Water     \-                200       200

  Tween 80                      T80            DMSO      \-                \-        500

  Zinc sulphate                 ZS             Water     126               \-        126
  ----------------------------------------------------------------------------------------------------

List of concentrations and vehicles used for each testing compound. 1) Kathon CG is a mixture of the compounds MC and MCI. The concentration of this mixture is given in %.

Chemical exposure of the cells
------------------------------

The human myeloid leukemia-derived cell line MUTZ-3 (DSMZ, Braunschweig, Germany) was maintained in α-MEM (Thermo Scientific Hyclone, Logan, UT) supplemented with 20% (volume/volume) fetal calf serum (Invitrogen, Carlsbad, CA) and 40 ng/ml rhGM-CSF (Bayer HealthCare Pharmaceuticals, Seattle, WA), as described \[[@B10]\]. Cultures were maintained at 200.000 cells/ml during expansion, with a media change every 3-4 days. No differentiating steps were performed. Instead, the proliferating progenitor MUTZ-3 was used for stimulations, as delivered by the supplier. Prior to each experiment, the cells were immunophenotyped using flow cytometry as a quality control. Cells were seeded in 6-well plates at 200.000 cells/ml. Stock solutions of each compound were prepared in either DMSO or distilled water, and were subsequently diluted so the in-well concentrations corresponded to the Rv90 value, and in-well concentrations of DMSO were 0.1%. Cells were incubated for 24 h at 37°C and 5% CO~2~. Thereafter, cells were harvested and analyzed by flow cytometry. In parallel, harvested cells were lysed in TRIzol reagent (Invitrogen) and stored at -20°C until RNA extraction. Stimulations with chemicals were performed in three individual experiments, so that triplicates samples were obtained.

Phenotypic analysis with flow cytometry
---------------------------------------

All cell surface staining and washing steps were performed in PBS containing 1% BSA (w/v). Cells were incubated with specific mouse mAbs for 15 min at 4°C. The following mAbs were used for flow cytometry: FITC-conjugated CD1a (DakoCytomation, Glostrup, Denmark), CD34, CD86, and HLA-DR (BD Biosciences), PE-conjugated CD14 (DakoCytomation), CD54 and CD80 (BD Biosciences). Mouse IgG1, conjugated to FITC or PE were used as isotype controls (BD Biosciences) and PI was used to assess cell viability. FACSDiva software was used for data acquisition with FACSCanto II instrument (BD Bioscience). 10,000 events were acquired and gates were set based on light scatter properties to exclude debris and nonviable cells. Further data analysis was performed using FCS Express V3 (De Novo Software, Los Angeles, CA).

Preparation of cRNA and gene chip hybridization
-----------------------------------------------

RNA isolation and gene chip hybridization was performed as described \[[@B41]\]. Briefly, RNA from unstimulated and chemical-stimulated MUTZ-3 cells, from triplicate experiments, were extracted and analyzed. The preparation of labeled sense DNA was performed according to Affymetrix GeneChip™ Whole Transcript (WT) Sense Target Labeling Assay (100 ng Total RNA Labeling Protocol) using the recommended kits and controls (Affymetrix, Santa Clara, CA). Hybridization, washing and scanning of the Human Gene 1.0 ST Arrays were performed according to the manufacturer\'s protocol (Affymetrix). The microarray data have been deposited in the Array Express database <http://www.ebi.ac.uk/arrayexpress/> with accession number E-MTAB-670.

Microarray data analysis and statistical methods
------------------------------------------------

The microarray data were normalized and quality checked with the RMA algorithm, using Affymetrix Expression Console (Affymetrix). Genes that were significantly regulated when comparing sensitizers with non-sensitizers were identified using one-way ANOVA, with false discovery rate (FDR) as a correction for multiple hypothesis testing. In order to reduce the large number of identified significant genes, we applied an algorithm developed in-house for Backward Elimination of analytes \[[@B42]\]. With this method, we train and test a Support Vector Machine (SVM) model \[[@B12]\] with leave-one out cross-validation, with one analyte left out. This process is iterated until each analyte has been left out once. For each iterative step, a Kullback-Leibler divergence (KLD) is recorded, yielding *N*KLDs, where *N*is the number of analytes. The analyte that was left out when the smallest KLD was observed is considered to provide the least information in the data set. Thus, this analyte is eliminated and the iterations proceed, this time with *N*-1 analytes. In this manner, the analytes are eliminated one by one until a panel of markers remain that have been selected based on the ability of each analyte to contribute with orthogonal information for the discrimination of skin sensitizers vs. non-sensitizers. The selected biomarker profile of 200 transcripts were designated the \"Prediction Signature\". The scripts for Backwards Elimination and Support Vector Machines were programmed for R \[[@B43]\], with the additional package e1071 \[[@B44]\]. ANOVA analyses and visualization of results with Principal Component Analysis were performed in Qlucore Omics Explorer 2.1 (Qlucore AB, Lund, Sweden). Hierarchical clustering for the heatmap was performed in R.

Interrogation of the method for identification of the Prediction Signature
--------------------------------------------------------------------------

The data set was divided into a training set and a test set, consisting of 70% and 30%, of the chemical compounds, respectively. The division was performed randomly, while maintaining the proportions of sensitizers and non-sensitizers in each subset at the same ratio as in the complete data set. A biomarker signature was identified in the training set, using ANOVA filtering and Backward Elimination, as described above. This test signature was used to train an SVM, using the training set, which was thereafter applied to predict the samples of the test set. The process was repeated 20 times and the distribution of the area under the Receiver Operating Characteristic (ROC) curve \[[@B45]\] was used as a measurement of the performance of the model.

Assessment of biological functions of Prediction Signature using pathway analysis
---------------------------------------------------------------------------------

In order to investigate the biological functions the gene profile of the 200 genes derived from the Backward Elimination was analyzed, using the Ingenuity Pathway Analysis software, IPA, (Ingenuity Systems, Inc. Mountain View, USA). The gene profile was analyzed using the \'Build\' and \'Path Explorer\' functions to build an interactome of the core genes from the Prediction Signature together with connecting molecules, as suggested by IPA. The molecules of the signature were connected using the shortest known paths. In this process only human data from primary cells, cell lines and epidermal tissue was used. Public identifiers were used to map genes in IPA. All molecules except for endogenous and chemical drugs were allowed in the network and all kinds of connections were allowed. Known \'Functions\' and \'Canonical Pathways\' from IPA were mapped to the signature using the \'Overlay\' function. The most densely populated pathways and functions were reported. All were significant, using the built in IPA statistical measures (p-values for functions and -log(p-values) for pathways).
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